Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy

Hassen S Wollebo1, Mahmut Safak, Luis Del Valle

  • 1Center for Neurovirology, Department of Neuroscience, Temple University School of Medicine, 3500 N. Broad Street, Philadelphia, PA 19140, USA.

Journal of Neuroimmunology
|December 28, 2010
PubMed

Insights

Tumor necrosis factor-alpha (TNF-α) may reactivate John Cunningham virus (JCV) in patients with HIV/AIDS. This reactivation could contribute to progressive multifocal leukoencephalopathy (PML) development.

Area of Science:

  • Neurovirology
  • Immunology
  • Molecular Biology

Background:

  • John Cunningham virus (JCV) establishes latent infections and is associated with progressive multifocal leukoencephalopathy (PML), a CNS demyelinating disease.
  • Reactivation of latent JCV is linked to conditions like HIV-1/AIDS, where proinflammatory cytokines are elevated in the brain.

Purpose of the Study:

  • To investigate the role of tumor necrosis factor-alpha (TNF-α), a key cytokine induced by HIV-1, in regulating JCV transcription and reactivation.
  • To explore the potential mechanism of TNF-α-mediated JCV reactivation via the NF-κB pathway.

Main Methods:

  • Assessed the effect of TNF-α on JCV early and late transcription in vitro.
  • Utilized a heterologous promoter containing the JCV κB element to confirm TNF-α responsiveness.
  • Performed immunohistochemistry on brain tissue from HIV-positive PML patients to detect TNF-α and its receptor, TNFR-1.

Main Results:

  • TNF-α significantly stimulated both early and late JCV transcription.
  • The JCV κB element was identified as conferring TNF-α responsiveness to a heterologous promoter.
  • Elevated levels of TNF-α and TNFR-1 were observed in the brain tissue of HIV-positive PML patients.

Conclusions:

  • TNF-α plays a role in regulating JCV transcription, suggesting it can promote viral reactivation.
  • The κB element is a critical mediator of TNF-α's effect on JCV.
  • These findings suggest that TNF-α-induced JCV reactivation via the κB pathway may contribute to the pathogenesis of PML in HIV-1/AIDS patients.

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...